Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading. J of Skin. 2023;7(2):s164. doi:10.25251/skin.7.supp.164